A cataract is an eye condition in which the lens becomes cloudy over time, thereby affecting eyesight. During cataract surgery, the clouded lens is removed and replaced with an artificial lens, which ...
When bilateral cataract surgery becomes necessary, many patients are faced with the alluring prospect of reducing or even eliminating the need to use spectacles for distance and near vision. Patients ...
Corneal refractive surgery has been performed on millions of patients to decrease their spectacle dependence. Most of these patients have high expectations of visual function—but as these patients age ...
Aims To evaluate the functional effect of bilateral implantation of two different multifocal intraocular lenses (IOL) compared with the standard monofocal IOL. Methods Sixty-nine patients were ...
To compare best-corrected visual acuity (BCVA) and contrast sensitivity (CS) under different levels of illumination in patients who had monofocal and multifocal intraocular lenses (IOLs) and to ...
Abbott has announced having received U S Food and Drug Administration approval for its Tecnis Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia, or ...
Lenstec Inc. has announced that its SBL-3 IOL has been approved by the FDA. ST. PETERSBURG, Fla., July 28, 2022 /PRNewswire/ -- The Lenstec SBL-3 IOL (Segmented Bifocal Lens) is a next-generation ...
More than three million cataract surgeries performed in Europe annually[1] Basel, Switzerland, June 16, 2015 - Alcon, the global leader in eye care and a division of Novartis, has received European CE ...
Alcon Inc., Aurolab, Bausch Lomb Corp., BVI Holdings Ltd., Carl Zeiss AG, EyeKon Medical Inc., HOYA CORP., HumanOptics Holding AG, Johnson and Johnson Services Inc ...
New York, March 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Intraocular Lens Market - Global Outlook & Forecast 2023-2028 ...
2.1.1 A cataract is the opacification of the eye's natural lens, usually causing gradual eyesight deterioration and potentially leading to blindness. 2.1.2 Current treatment involves replacing the ...
poses a challenge. Key market players include Alcon Inc., Aurolab, Bausch Lomb Corp., BVI Holdings Ltd., Carl Zeiss AG, EyeKon Medical Inc., HOYA CORP., HumanOptics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results